...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Great Presetation today
3
Oct 17, 2017 03:14PM
3
bfw
Oct 17, 2017 07:16PM
4
Oct 18, 2017 06:20AM
5
Oct 18, 2017 02:17PM
4
Oct 18, 2017 04:27PM
4
Oct 18, 2017 06:11PM
3
Oct 19, 2017 09:40AM
5
Oct 19, 2017 10:45AM
1
Oct 19, 2017 02:51PM
4
Oct 19, 2017 07:22PM
2
Oct 20, 2017 02:04AM
3
Oct 20, 2017 10:35AM

And Zenith is on the schedule for BIO Europe coming up Nov 6-8 in Berlin, so maybe we'll see an updated data set on the combo trial then. I think Zenith presents Nov 7th as of the schedule I saw 10/20.

3
Oct 23, 2017 12:27PM
3
Oct 24, 2017 02:27AM
4
Oct 24, 2017 01:39PM
Share
New Message
Please login to post a reply